CCSD code 0037G: Mdm2 gene amplification test guide
CCSD code 0037G identifies Mdm2 gene amplification testing, a pathology and diagnostic investigation code used across UK private healthcare to bill major insurers for genetic and molecular testing.
CCSD code 0040G: MRD genomic sequencing for blood cancers
CCSD code 0040G is the code independent pathology labs use to bill UK private medical insurers for MRD genomic sequencing in blood cancers. Simple enough on paper. In practice, it’s one of the pathology codes most likely to be coded correctly and still come back unpaid. It belongs to the CCSD Schedule, the coding system […]
CCSD code 0048C: Potassium level test and UK private billing
CCSD code 0048C is the code UK private medical insurers use to bill a potassium level test, the blood chemistry check that almost never travels alone. Order “U&Es” and potassium comes back bundled with sodium, urea, and creatinine from the same draw. If a remittance or invoice line shows 0048C, that’s the charge for the […]
CCSD code 0042G: CCND1 t(11;14) genetic test billing guide
CCSD code 0042G identifies the CCND1 t(11;14) test, a molecular pathology test that detects a specific chromosomal translocation in a patient sample. It sits in the biochemistry genetic analysis section of the CCSD (Clinical Coding and Schedule Development) schedule, the code list UK private medical insurers use to process claims. This guide covers what the […]
CCSD code 0504G: YMDD mutation test billing guide
CCSD code 0504G is the code UK private medical insurers recognise for the YMDD mutation test, a genetic analysis that checks a hepatitis B virus (HBV) sample for mutations in the YMDD motif of the viral polymerase gene. The name comes from the four amino acids the motif encodes: Tyrosine, methionine, aspartate, aspartate. Mutations here […]
CCSD code 0132B: Thallium level test billing guide
CCSD code 0132B identifies the thallium level blood test, a diagnostic pathology code within the CCSD Schedule of Diagnostic Tests used across UK private healthcare. Practitioners typically order it to investigate suspected thallium exposure or poisoning: Unexplained hair loss, peripheral nerve pain, or gastrointestinal symptoms following possible contact with the metal. That’s the exact clinical […]
CCSD Code 0029B: MLH1 promoter hypermethylation test
CCSD Code 0029B is a pathology procedure code in the CCSD schedule, used across UK private healthcare to bill for MLH1 promoter hypermethylation testing. It sits in Chapter 34, the pathology chapter, and the final letter, B, shows the test runs on a blood sample. MLH1 promoter hypermethylation is an epigenetic change that switches off […]
CCSD code 0022G: C-MYC gene test billing guide
CCSD code 0022G covers single gene C-MYC (MYC) testing, a molecular pathology test UK insurers reimburse with prior authorization.
CCSD code 0024B: BH4 pre compounding test billing guide
CCSD code 0024B is the BH4 pre compounding test, a diagnostic code listed in the Pathology chapter of the CCSD Schedule and used to bill UK private medical insurers. Because it is a diagnostic test code rather than a procedure code, it’s submitted and paired differently from the surgical codes most billing guides describe. This […]
CCSD code 0006G: KRAS mutation analysis
CCSD code 0006G is the code UK private medical insurers recognise for KRAS mutation analysis, a molecular pathology test that checks a tumour sample for mutations in the KRAS gene. Because KRAS status shapes targeted-treatment decisions in cancers such as colorectal and non-small cell lung cancer, the test is usually requested by an oncologist and […]